VHIO Clinical Research Program, HUVH ICS

Spain

1 July 2019 - 30 June 2020

No articles found. VHIO Clinical Research Program, HUVH ICS did not contribute to any primary research papers from Nature Index journals in the current 12 month window.

Catalan Health Institute (ICS)

↳ Vall d'Hebron University Hospital (HUVH), ICS

↳ Vall d'Hebron Institute of Oncology (VHIO), HUVH ICS

↳ VHIO Clinical Research Program, HUVH ICS

Gastrointestinal and Endocrine Tumors Group, HUVH ICS

Cancer Genomics Group, HUVH ICS

VHIO Preclinical Research Program, HUVH ICS

Experimental Therapeutics Group, HUVH ICS

VHIO Translational Research Program, HUVH ICS

Gene Expression and Cancer Group, HUVH ICS

Stem Cells and Cancer Group, HUVH ICS

Department of Cardiology, HUVH ICS

Department of Infectious Diseases, HUVH ICS

Department of Internal Medicine I, HUVH ICS

Department of Neurology, HUVH ICS

Department of Psychiatry, HUVH ICS

Multiple Sclerosis Centre of Catalonia (CEMCAT), HUVH ICS

Vall d'Hebron Research Institute (VHIR), HUVH ICS

CIBBIM-Nanomedicine, VHIR ICS

Neurosciences Research, VHIR ICS

Neurovascular Research Laboratory (LIN-BCN), VHIR ICS

Hospital de Viladecans (HV), ICS

Hospital de Tortosa Verge de la Cinta (HTVC), ICS

Programa Corporatiu "Neurodevelopment Disorders Along Life Span", ICS

Arnau de Vilanova University Hospital (HUAV), ICS

Bellvitge University Hospital (HUB), ICS

Servicio de Medicina Interna, HUB ICS

Department of Rheumatology, HUB ICS

Institute of Neuropathology, HUB ICS

Dr. Josep Trueta University Hospital (HUJT), ICS

Germans Trias i Pujol University Hospital (HUGTP), ICS

Institute for AIDS Research (IrsiCaixa)

Institute for Health Science Research Germans Trias i Pujol (IGTP), HUGTP ICS

Institute of Predictive and Personalized Medicine of Cancer (IMPPC), IGTP ICS

Joan XXIII University Hospital, ICS

Return to institution outputs

Latest supplement

Nature Index 2020 Science Cities

Nature Index Science cities showcases the top 100 cities in the Nature Index and the stories of success behind the top 5, examining their strengths, challenges and paths ahead.

Access free